CreaGen Biosciences

CreaGen is a contract research organization (CRO) specializing in medicinal chemistry and drug discovery services. Founded in 2003, it offers integrated chemistry services including lead generation and optimization, synthetic chemistry, bioconjugation chemistry, and preclinical drug discovery research, with expertise in small molecules, ADCs, nucleoside/nucleotide chemistry, peptides, and peptide nucleic acids. The company operates a 22,000 sq ft state-of-the-art facility and collaborates with over 50 biotech/pharma companies, academic institutions, and federal agencies, including a significant IDIQ contract with NIAID for HIV therapeutics preclinical services.